111results about How to "Minimize migration" patented technology

The present invention relates to novel drug depot implant designs for optimal delivery of therapeutic agents to subjects. The invention provides a method for alleviating pain associated with neuromuscular or skeletal injury or inflammation by targeted delivery of one or more therapeutic agents to inhibit the inflammatory response which ultimately causes acute or chronic pain. Controlled and directed delivery can be provided by drug depot implants, comprising therapeutic agents, specifically designed to deliver the therapeutic agent to the desired location by facilitating their implantation, minimizing their migration from the desired tissue location, and without disrupting normal joint and soft tissue movement.

The present invention relates to novel drug depot implant designs for optimal delivery of therapeutic agents to subjects. The invention provides a method for alleviating pain associated with neuromuscular or skeletal injury or inflammation by targeted delivery of one or more therapeutic agents to inhibit the inflammatory response which ultimately causes acute or chronic pain. Controlled and directed delivery can be provided by drug depot implants, comprising therapeutic agents, specifically designed to deliver the therapeutic agent to the desired location by facilitating their implantation, minimizing their migration from the desired tissue location, and without disrupting normal joint and soft tissue movement.

The present invention relates to novel drug depot implant designs for optimal delivery of therapeutic agents to subjects. The invention provides a method for alleviating pain associated with neuromuscular or skeletal injury or inflammation by targeted delivery of one or more therapeutic agents to inhibit the inflammatory response which ultimately causes acute or chronic pain. Controlled and directed delivery can be provided by drug depot implants, comprising therapeutic agents, specifically designed to deliver the therapeutic agent to the desired location by facilitating their implantation, minimizing their migration from the desired tissue location, and without disrupting normal joint and soft tissue movement.

Disclosed are methods useful for treating vascular lesions wherein a non-particulate agent such as a metal coil is introduced into a vascular site (e.g., an aneurysm cavity) in conjunction with an embolizing composition comprising a biocompatible polymer and a biocompatible solvent.The biocompatible solvent is miscible or soluble in blood and also solubilizes the polymer during delivery. The biocompatible polymer is selected to be soluble in the biocompatible solvent but insoluble in blood. Upon contact with the blood, the biocompatible solvent dissipates from the embolic composition whereupon the biocompatible polymer precipitates. Precipitation of the polymer in the presence of the non-particular agent permits the agent to act as a structural lattice for the growing polymer precipitate.In another embodiment, the biocompatible polymer composition can be replaced with a biocompatible prepolymer composition containing a biocompatible prepolymer.

A brush having antimicrobial characteristics that inhibit bacterial growth. The antimicrobial agents, compounds or chemicals are embedded in either the body or bristles or both of the brush. Further, the present invention is a method of manufacturing a brush having antimicrobial characteristics that inhibit bacterial growth. An antimicrobial additive is incorporated in resin concentrate form into the amorphous zones of the molecular structure of the polymer from which brush handles are injection molded, thereby incorporating the antimicrobial agent into the brush handle. The antimicrobial additive in the body of the brush, incorporated in the manner above, results in substantive controlled migration from the body to the bristles, until a point of equilibrium is reached. The invention is suitable for any brush in which bristles are embedded in plastic, including toothbrushes, hair brushes, scrub brushes, toilet bowl brushes, cosmetic brushes, lip-color brushes, etc.

This invention relates to methods and devices that improve cell culture efficiency. They include the use of gas permeable culture compartments that reduce the use of space while maintaining uniform culture conditions, and are more suitable for automated liquid handling. They include the integration of gas permeable materials into the traditional multiple shelf format to resolve the problem of non-uniform culture conditions. They include culture devices that use surfaces comprised of gas permeable, plasma charged silicone and can integrate traditional attachment surfaces, such as those comprised of traditional tissue culture treated polystyrene. They include culture devices that integrate gas permeable, liquid permeable membranes. A variety of benefits accrue, including more optimal culture conditions during scale up and more efficient use of inventory space, incubator space, and disposal space. Furthermore, labor and contamination risk are reduced.

Methods and devices are provided to contribute to improved stent graft fixation within vessels at treatment sites. Improved stent graft fixation within vessels at treatment sites is provided by providing stent grafts and methods of making and using stent grafts having structural scaffoldings which undergo controlled galvanic corrosion in situ. Other embodiments include stent grafts having galvanic cells attached to the vessel luminal wall-contacting sides. Still other embodiments include stent grafts that undergo controlled galvanic corrosion and include at least one additional cell growth promoting factor.

A battery operated atomizer device comprising, in a housing (22), a liquid reservoir (30) from which a capillary type liquid delivery system (38) extends to contact a piezoelectric actuator an atomization plate assembly (34), the assembly (34) being supported by means of wire-like elements (36) in cantilever fashion over the liquid delivery system, the liquid delivery system comprising an outer tubular member (52) and a solid rod (56) which have facing surfaces configured to define between them, longitudinal capillary liquid passages.

A collapsible gastrointestinal anchor can be characterized in various embodiments by a radial force of about 0.1 Newtons (N) or greater at a compressed diameter of 25 millimeters (mm); by an average spring rate of about 13 Newtons / meter (N / m) or greater in a range of motion between a relaxed diameter and a compressive elastic deformation diameter; or by a radial force over the range of motion of about 0.1 N or greater. Typically, the anchor can be adapted to be retained within a subject's intestine, more typically in the duodenum, or particularly in the duodenal bulb just distal to the pylorus.A gastrointestinal implant device includes the collapsible gastrointestinal anchor and a floppy sleeve. The sleeve is open at both ends and adapted to extend into a subject's intestine, the anchor being coupled to a proximal portion of the sleeve.Also include are methods of implanting the gastrointestinal implant device in a subject, and methods of treating a subject for disease.The disclosed gastrointestinal invention leads to an improved ability to secure anchors and devices in the gastrointestinal tract while tending to minimize migration.

A device for expanding tissue comprises at least one fluid delivery tube and at least one fluid delivery element in fluid communication with the at least one fluid delivery tube. The at least one fluid delivery tube comprises a proximal end, a distal end, and a lumen therebetween. The device is constructed and arranged to perform a near full circumferential expansion of luminal wall tissue. Systems and methods are also provided, including a system for expanding tissue layers and treating tissue proximate to the expanded tissue layers.

A sacrificial anode stent system comprises a stent having at least one sacrificial anode portion and a vaso-occlusive device. The vaso-occlusive device has at least one portion with a potential different from that of the sacrificial anode portion of the stent.

Methods of producing a biocompatible polysaccharide gel composition having sustained release properties are disclosed. Also disclosed is a biocompatible polysaccharide gel composition having sustained release properties, a method of treating a disease or condition using the present biocompatible polysaccharide gel composition, and a method of controlling rate of release of at least one target solute from the biocompatible polysaccharide gel composition. Pharmaceutical compositions which include the present biocompatible polysaccharide gel composition also are disclosed.

A sacrificial anode stent system comprises a stent having at least one sacrificial anode portion and a vaso-occlusive device. The vaso-occlusive device has at least one portion with a potential different from that of the sacrificial anode portion of the stent.

A wipe includes a substrate with a pouch configured on an application side thereof. An access opening is provided into an internal space of the pouch. A composition delivered by the wipe upon use of the product is stored in a container that is inserted into the pouch through the access opening. Upon use of the wipe, the container within the pouch releases the composition, which is delivered through the pouch for application by the wipe.

An implantable adjustable body tissue cuff, apparatus and method. The cuff is an elastomeric strap of biocompatible non-conductive material. The strap's tail and head provide adjustable length fastening by a) the tail being formed with longitudinally spaced, laterally paired locking projections and the head being formed with one or more locking apertures; or b) the tail being formed with longitudinally spaced locking apertures and the head being formed with one or more laterally paired locking projections. The locking projection shape allows for passage through the locking aperture, while restricting movement in a reverse direction. The cuff accommodates devices such as tissue stimulators or recorders, with conductive elements attached, imbedded, or printed on the strap body. The cuff is intra-operatively adjusted to optimize placement and contact between conductive elements and body tissue, without tissue damage. This cuff accommodates varying tissue diameters and simplifies manufacture and surgical placement.

Methods, apparatus and precursors for producing substantially water-free silica soot, preforms and glass. The methods and apparatus make substantially water-free fused silica preforms or glass by removing water as a reaction product, removing water from the atmosphere, removing water from the transport process, or combinations thereof. In a first embodiment, substantially water-free soot, preforms or glass are achieved by using a hydrogen-free fuel, such as carbon monoxide, in the deposition process. In another embodiment, a soot producing burner has parameters that enable operation on a substantially hydrogen-free fuel. End burners, which minimize water production, are also described. Such water-free methods are useful in depositing fluorine-doped soot because of the low water present and the efficiency in which fluorine is incorporated. In another embodiment, glassy barrier layer methods and apparatus are described for minimizing dopant migration, especially fluorine. Laser and induction methods and apparatus for forming the barrier layer are depicted. A chlorine, fluorine and silica precursor, such as chlorofluorosilane, may be utilized to form fluorinated soot. Other methods and apparatus are directed to combinations of conventional and substantially water-free processes. One embodiment is directed to combustion enhancing additives for addition to the substantially hydrogen-free fuels. The methods and apparatus in accordance with the invention are particularly useful for producing photomask substrates and optical fiber preforms.

A wipe includes a substrate with a pouch configured on an application side thereof. An access opening is provided into an internal space of the pouch. A composition delivered by the wipe upon use of the product is stored in a container that is inserted into the pouch through the access opening. Upon use of the wipe, the container within the pouch releases the composition, which is delivered through the pouch for application by the wipe.